Study supports allergy vaccine using genetically engineered pollen

08/10/2004 | Forbes

Researchers report the first-ever trial on an allergy vaccine developed from genetically engineered pollen shows promise in treating the condition by triggering a strong immune response in the body. The vaccine is seen as a replacement for immunotherapy, a common treatment for allergies that sometimes can make the problem worse.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
AIMD Product Expert
BSI
Nationwide, SL_Nationwide
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Finance Manager - ENT
Medtronic
Jacksonville, FL
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA